PL2402363T3 - Sposób zwiększania rozpuszczalności metioniny poprzez dodanie substancji mineralnych i działanie kwasem - Google Patents

Sposób zwiększania rozpuszczalności metioniny poprzez dodanie substancji mineralnych i działanie kwasem

Info

Publication number
PL2402363T3
PL2402363T3 PL10746471T PL10746471T PL2402363T3 PL 2402363 T3 PL2402363 T3 PL 2402363T3 PL 10746471 T PL10746471 T PL 10746471T PL 10746471 T PL10746471 T PL 10746471T PL 2402363 T3 PL2402363 T3 PL 2402363T3
Authority
PL
Poland
Prior art keywords
methionine
solubility
increasing
acid treatment
mineral addition
Prior art date
Application number
PL10746471T
Other languages
English (en)
Inventor
So Young Kim
Yong Uk Shin
In Kyung Heo
Hyun Ah Kim
Ju Eun Kim
Chang Il Seo
Sung Kwang Son
Sang Mok Lee
Sung Hoo Jhon
Han Jin Lee
Kwang Ho Na
Il Chul Kim
Original Assignee
Cj Cheiljedang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cj Cheiljedang Corp filed Critical Cj Cheiljedang Corp
Publication of PL2402363T3 publication Critical patent/PL2402363T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/12Methionine; Cysteine; Cystine
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/26Separation; Purification; Stabilisation; Use of additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
PL10746471T 2009-02-27 2010-02-26 Sposób zwiększania rozpuszczalności metioniny poprzez dodanie substancji mineralnych i działanie kwasem PL2402363T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020090016605A KR101164711B1 (ko) 2009-02-27 2009-02-27 미네랄 첨가와 산처리를 이용하여 메치오닌의 용해도를 증가시키는 방법
PCT/KR2010/001254 WO2010098632A2 (ko) 2009-02-27 2010-02-26 미네랄 첨가와 산처리를 이용하여 메치오닌의 용해도를 증가시키는 방법
EP10746471.1A EP2402363B1 (en) 2009-02-27 2010-02-26 Method for increasing the solubility of methionine by mineral addition and acid treatment

Publications (1)

Publication Number Publication Date
PL2402363T3 true PL2402363T3 (pl) 2014-08-29

Family

ID=42666091

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10746471T PL2402363T3 (pl) 2009-02-27 2010-02-26 Sposób zwiększania rozpuszczalności metioniny poprzez dodanie substancji mineralnych i działanie kwasem

Country Status (9)

Country Link
US (2) US20120136058A1 (pl)
EP (1) EP2402363B1 (pl)
JP (1) JP5591263B2 (pl)
KR (1) KR101164711B1 (pl)
CN (1) CN102333787B (pl)
ES (1) ES2477220T3 (pl)
MY (1) MY153916A (pl)
PL (1) PL2402363T3 (pl)
WO (1) WO2010098632A2 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169343A (en) 2010-12-29 2019-03-21 Cj Cheiljedang Corp Methods for production of l-methionine and related products
BR112018013873A2 (pt) * 2016-01-08 2018-12-18 Evonik Degussa Gmbh método para a produção fermentativa de l-metionina e/ou seus derivados
KR20180078621A (ko) * 2016-12-30 2018-07-10 씨제이제일제당 (주) 결정화 기술을 이용한 l-메티오닌 결정의 제조방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2443391A (en) * 1945-09-26 1948-06-15 Du Pont Methionine isolation process
DE2259159C3 (de) * 1972-12-02 1980-01-10 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt Verfahren zur Herstellung von lagerungsstabilem Methionin
US3941818A (en) * 1973-08-20 1976-03-02 Zinpro Corporation 1:1 Zinc methionine complexes
US3950372A (en) * 1974-07-03 1976-04-13 Zinpro Corporation 1:1 Manganese alpha amino acid complexes
KR880002033B1 (ko) * 1986-05-31 1988-10-13 주식회사 동양금속화학 아연, 철, 구리-메치오닌 컴플렉스의 제조방법
US4764633A (en) 1987-08-31 1988-08-16 Zinpro Corporation Ferric ion catalyzed complexation of zinc and/or manganese with alpha amino acids
US5278329A (en) * 1992-02-21 1994-01-11 Zinpro Corporation L-form 1:1 metal methionine complexes
US5504055A (en) * 1994-03-15 1996-04-02 J.H. Biotech, Inc. Metal amino acid chelate
US5430164A (en) * 1994-10-18 1995-07-04 Zinpro Corporation Enhanced solubilization of zinc and manganese methionine complex salts by addition of ferric ion
JP2002047266A (ja) * 2000-07-27 2002-02-12 Res Inst For Prod Dev メチオニン・遷移金属錯体およびアミノ酸を含む組成物
US8338141B2 (en) 2003-07-08 2012-12-25 Novus International, Inc. Methionine recovery processes
KR20050110167A (ko) * 2004-05-18 2005-11-23 주식회사 중앙바이오텍 금속-메치오닌 1:1 복합체의 제조방법
KR100481326B1 (ko) * 2004-06-22 2005-04-07 주식회사 동암비티 유기태 킬레이트의 제조방법
MY158845A (en) * 2005-12-21 2016-11-15 Abbott Lab Induced-viscosity nutritional emulsions
US8007846B2 (en) * 2006-01-18 2011-08-30 Albion International, Inc. Mixed amino acid/mineral compounds having improved solubility
KR100905381B1 (ko) 2006-07-28 2009-06-30 씨제이제일제당 (주) L-메치오닌 전구체 생산 균주 및 상기 l-메치오닌전구체로부터의 l-메치오닌 및 유기산의 생산방법
TR201821029T4 (tr) 2007-02-23 2019-01-21 Merck Sharp & Dohme Geliştirilmiş antı-IL-23p19 antikorları.

Also Published As

Publication number Publication date
CN102333787B (zh) 2014-05-21
EP2402363A4 (en) 2012-11-28
JP5591263B2 (ja) 2014-09-17
CN102333787A (zh) 2012-01-25
KR101164711B1 (ko) 2012-07-11
EP2402363B1 (en) 2014-04-16
EP2402363A2 (en) 2012-01-04
US20120136058A1 (en) 2012-05-31
WO2010098632A2 (ko) 2010-09-02
ES2477220T3 (es) 2014-07-16
US20170016037A1 (en) 2017-01-19
WO2010098632A3 (ko) 2011-04-07
KR20100097783A (ko) 2010-09-06
MY153916A (en) 2015-04-15
JP2012518684A (ja) 2012-08-16

Similar Documents

Publication Publication Date Title
IL261526A (en) Methods for the purification of deoxycholic acid
HK1217763A1 (zh) 用於治療疾病的方法
IL220211A0 (en) Process for the preparation of 1-alkyl-/1-aryl-5-pyrazolecarboxylic acid derivatives
EP2350641A4 (en) Methods of Treatment
HK1176870A1 (zh) 疾病的治療方法
PL2442811T3 (pl) Teobromina w terapii kaszlu
EP2402363A4 (en) PROCESS FOR INCREASING THE SOLUBILITY OF METHIONINE BY ADDING MINERALS AND ACIDIC TREATMENT
EP2454229A4 (en) AMINO ACID DERIVATIVES FOR THE TREATMENT OF NEUROPATHIC PAIN
EP2385994A4 (en) AGGLOMERATION PROCESS
EP2424539A4 (en) PROCESS FOR TREATING DEPRESSION
PL389594A1 (pl) Sposób wytwarzania sulfidów fluorohalogenometyloarylowych
EP2440238A4 (en) Methods of Treatment
GB0904164D0 (en) Method of treatment
GB0909807D0 (en) Method of treatment
GB0921823D0 (en) Method of treatment
EP2532254A4 (en) METHOD FOR PROCESSING A LACTO-N BIOSE-CONTAINED SOLUTION
GB0823435D0 (en) Method of treatment
AU2009903360A0 (en) Method of Treatment